H35.172
Retrolental fibroplasia, left eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Retrolental fibroplasia, now more commonly called retinopathy of prematurity (ROP), is a condition that affects the eyes of premature infants. It involves abnormal blood vessel development in the retina, the light-sensitive tissue at the back of the eye. When this condition occurs specifically in the left eye, it is classified under ICD-10 code H35.172. Early detection and management are important to prevent vision problems or blindness. This article provides a simple overview of the condition, its causes, symptoms, diagnosis, and possible treatments.
Causes & Symptoms
Clinical Causes: Premature birth, especially before 31 weeks of gestation Low birth weight, typically less than 1500 grams (3 pounds, 3 ounces) Oxygen therapy administered to premature infants, particularly if doses are high or prolonged, which can influence abnormal blood vessel growth in the retina Genetic predisposition may play a role, although it is less clearly understood
Key Symptoms: Leukocoria (white reflection from the retina that may be seen in photographs) Strabismus (crossed eyes or misaligned eyes) Poor visual response or nystagmus (involuntary eye movements) Blurred vision or partial vision loss in the affected eye In more advanced cases, visible abnormalities on examination may be evident without noticeable symptoms
Diagnostic & Treatment
Diagnosis Path: Diagnosis is typically made through a comprehensive eye examination, especially in premature infants. The eye care specialist will perform a dilated retinal exam, often using specialized instruments to look at the blood vessels in the retina. The staging of ROP is based on the severity of blood vessel abnormality, with more advanced stages requiring urgent attention. Additional imaging techniques like retinal photography or fluorescein angiography may be used to evaluate the extent of the condition and guide treatment decisions.
Treatment Protocols: Treatment options depend on the severity and stage of the disease, with the goal of preventing progression and preserving vision. These options include: - Observation: Mild cases may simply be monitored regularly to track progression. - Laser therapy: Applying laser burns to abnormal blood vessels to stop abnormal growth and prevent retinal detachment. - Cryotherapy: A freezing treatment used historically for more advanced cases, now less common. - Intravitreal injections: Medications like anti-VEGF agents may be used to inhibit abnormal blood vessel growth. - Surgery: In cases where retinal detachment has occurred, surgical interventions such as scleral buckle or vitrectomy might be necessary. Since early intervention can make a significant difference, prompt diagnosis and management are essential to prevent long-term visual impairment.
Clinical Advice & FAQs
Billing Guidance
Is H35.172 a billable ICD-10 code?
Yes, H35.172 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.172?
Clinical documentation must specify the nature of Retrolental fibroplasia, left eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference